Innovative CCO @ Biosynth driving new business and new product roadmap with our global lifescience customer base
Nipah virus outbreak in kerala ,India. as Nipah virus re -emerges with an ongoing outbreak in kerala, Biosynth has developed a monoclonal antibody to screen and detect the virus to help monitor and treat the disease at source . If you are a scientist or researcher looking at this virus please feel free to reach out to us at biologics@biosynth.com
Aalto Bio Reagents has moved the ongoing content from this LinkedIn channel to Biosynth's LinkedIn page please follow us there. https://lnkd.in/gMgfu-YZ
We are thrilled to announce that Aalto Bio Reagents has been named "Exporter of the Year" in the Life Sciences industry at the Irish Exporters Association Export Industry Awards 2023 This award is a testament to our team's dedication and our commitment to providing top-quality products to customers worldwide. Thanks to our incredible customers and partners for their trust and support. This recognition inspires us to keep pushing boundaries in the life sciences field. #lifescience #ivdindustry #invitrodiagnistics #exporter #exportawards2023
Following the outbreak of the Nipah virus in India. The Indian authorities have instituted a mass testing for the deadly virus that has killed two people in Kerela. We have developed a monoclonal antibody to screen and detect the virus. This MAb can help detect, monitor and treat the disease at source. If you are a scientist or a researcher looking at this virus please feel free to reach out to us at biologics@biosynth.com and we'll be happy to help. We also hope that everyone's safe and healthy!
We are excited to share that we have seen an increased interest in our Human Hybrid IgM Monoclonal antibody range. We look forward to keep innovating and creating products that help boost development. Click on the link below for further details regarding our antibody range or email dub.sales@biosynth.com for further information. https://rb.gy/3etpd #diseasestateplasma #biosynth #antibodies #monoclonalantibodies #plasma #plasmashortage #IgM #creativesolutions #innovation
